SOX9 antibody
Quick Overview for SOX9 antibody (ABIN1109113)
Target
See all SOX9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognizes SOX9
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Purified
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS, 0.05 % Sodium Azide, 0.5 % protein stabilizer
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Alternative Name
- SOX9
-
Background
- The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.Synonyms: CMD1, CMPD1, SRA1, SRY (sex determining region Y)-box 9, SRY-box 9, Transcription factor SOX-9
-
Molecular Weight
- 56 kDa
-
Gene ID
- 6662
-
Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
Target
-